BharatRohan’s hyperspectral imaging technology demonstrates promising results in identifying adulterated pharmaceutical tablets without damaging samples; company explores regulatory validation. GURUGRAM, India, Nov. 12, 2026 /PRNewswire/ — BharatRohan Airborne Innovations Limited has achieved a significant internal technology milestone in pharmaceutical quality screening. In controlled proof-of-concept testing, its proprietary hyperspectral imag…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.